Salute e Benessere

Update on ConfIdeS Phase 3 trial of imlifidase in highly sensitized kidney…

To accelerate randomization, Hansa has increased overall site activation up to 25 sites, continued enrollment beyond the targeted 64 patients, and amended the trial protocol to potentially facilitate a broader set of donors for organ allocation. Currently, 87 patients are enrolled in the trial at 16 activated trial sites with nine additional sites being initiated. To accelerate randomization, Hansa has increased overall site activation up to 25 sites, continued enrollment beyond the targeted…
PR Newswire
11/10/2023

Eurobio Scientific : Results for the First Half of 2023

RESULTS FOR THE FIRST HALF OF 2023Solid performance of Core Business and acceleration of strategic deployment First positive effects of the GenDx acquisition completed in October 2022:Strong half-year sales growth: core business up 37%Share of proprietary products up at 30% of salesIncreased internationalization, with 35% of sales generated outside FranceGross margin 1maintained at a high level (46.5% vs 48.5%)EBITDA 1margin at 23% in a context of...
Nasdaq GlobeNewswire
11/10/2023

Casino Group: Extension of the accession period to the lock-up agreement

Extension of the accession period to the lock-up agreement relating to the financial restructuring of the Group Paris, 11 October 2023Further to its press release of 5 October 2023, Casino Group announces that it has extended until Friday 13 October 2023 at 18:00 (CET) the last accession date to accede to the lock-up agreement (the " Lock-up Agreement ") relating to its financial restructuring entered into on 5 October 2023, in order to benefit from the support fee for acceding to…
Nasdaq GlobeNewswire
11/10/2023

Valneva to Present on Chikungunya at Several Leading Scientific Conferences

Saint-Herblain (France), October 11, 2023–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today it will present on the mosquito-borne chikungunya disease at several leading scientific conferences during the fourth quarter of 2023.AtIDWeek, the annual meeting of theInfectious Diseases Society of America (IDSA), Valneva will support the roundtable discussion “Chikungunya is an Increasing Global Threat: The Need for Better Protection” taking...
Nasdaq GlobeNewswire
11/10/2023

HLA Typing for Transplant Market worth $1.1 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742 Browse in-depth TOC on "HLA Typing for Transplant Market" 159 - Tables 42 - Figures 212 - Pages HLA Typing for Transplant Market Scope: Based on the product and service, the reagents & consumables segment held the largest share of the market in 2022. Based...
PR Newswire
11/10/2023

Reshaping Tuberculosis Disease Market Vertical with DLI's Drug Insights…

Continuous R&D activities are being conducted with an aim to develop high advanced tuberculosis treatment solutions. DLI has been a forefront in assisting the players in their drug development endeavours. The Tuberculosis Disease Market players procure DLI's healthcare consulting services to accelerate various activities. DLI helps them with treatment gaps identification, clinical trial feasibility analysis, commercial strategy analysis, drug launch strategies, along with pricing and market…
PR Newswire
11/10/2023

Redefining Tetanus Disease Market Analysis with DLI's Epidemiology Study, Drug…

Disease Landscape Insights health consultant has been playing an indispensable role in assisting Tetanus Disease Market players in researching diseases and developing comprehensive strategies for diagnosis, treatment, and tetanus prevention. It has been empowering them with disease insights, regulatory guidelines information, and overall market intelligence. It has been supporting them in treatment gaps identification, clinical trial assessment, clinical trial feasibility analysis, along with…
PR Newswire
11/10/2023

Advances in Stroke Disease Market Insights: Expediting Drug Development…

The prevalence of stroke is increasing over time. This has a lot to do with the unhealthy lifestyle habits of the masses. Medical researchers, pharma organizations, and related bodies are striving to improve the stroke management vertical by introducing effective stroke diagnosis and treatment therapeutics. DiseaseLandscape Insights is guiding many such players in their noble efforts. The prevalence of stroke is increasing over time. This has a lot to do with the unhealthy lifestyle habits of...
PR Newswire
11/10/2023

Refrigerants Market size worth USD 22.50 Billion, Globally, by 2027 at 4.40%…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=22339 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=22339 Browse in-depth TOCon" Refrigerants Market " 202 - Pages 126 – Tables 37 – Figures Global Refrigerants Market: A Revolution in Cooling Technology In a groundbreaking evolution that traces its roots back to 1856, the refrigerants industry has undergone transformative advancements,...
PR Newswire
11/10/2023

Exploring Salmonellosis Disease Market with DLI's Epidemiology Study, Clinical…

Alarming Salmonella statistics 2023 revealed by the Centers for Disease Control and Prevention (CDC) estimate that over 1.35 million cases of this illness are registered in the U.S. every year with 26,500 hospitalizations and 420 deaths. This increased disease burden has become a cause of concern for various nations across the globe. Alarming Salmonella statistics 2023 revealed by the Centers for Disease Control and Prevention (CDC) estimate that over 1.35 million cases of this illness are...
PR Newswire
11/10/2023

Game-Changing Research Intelligence in Cardiovascular Disease Landscape by…

DLI offers extensive regulatory consulting, price consulting, market access consulting, clinical trial regulatory consulting, reimbursement consulting, and commercialization support, among others. This allows the players to optimize the entire drug development process with adherence to all the needed regulatory standards. DLI offers extensive regulatory consulting, price consulting, market access consulting, clinical trial regulatory consulting, reimbursement consulting, and commercialization...
PR Newswire
11/10/2023

MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA…

MoonLake Immunotherapeutics presents positive 12-week data from thePhase 2 MIRA trial with Nanobody ®Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology CongressPeer reviewed data presented during a late-breaking session at the European Academy of Dermatology and Venereology Congress (EADV) confirms the strong profile of sonelokimab in HS announced at MLTX's R&D Day on June 26, 2023HiSCR75 primary endpoint met with a...
Nasdaq GlobeNewswire
11/10/2023

Exploring Emphysema Disease Market Growth with DLI's Drug Insights, Pricing and…

Disease Landscape Insights has been playing a significant role in educating the Emphysema Disease Market players about this ailment. From providing comprehensive disease overview to assisting them in the drug development endeavours, DLI's healthcare consulting services are indeed commendable. Further, it has been helping the industry participants with treatment gaps identification, clinical trial feasibility analysis, commercial strategy analysis, product pipeline analysis, and product portfolio…
PR Newswire
11/10/2023

Dental 3D Printing Market size worth USD 9124 Million, Globally, by 2028 at…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=12273 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=12273 Browse in-depth TOCon" Dental 3D Printing Market " 202 - Pages126 – Table 37 – Figures Innovative Dental 3D Printing Market Revolutionizes Digital Dentistry Dental 3D printing (3DP), recognized as additive manufacturing, is reshaping the landscape of digital dentistry. Since its...
PR Newswire
11/10/2023

Wound Care Market worth $28.6 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=371 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=371 Browse in-depth TOC on "Wound Care Market"200 - Tables50 - Figures300 - Pages Wound Care Market Scope: The advanced wound care products segment accounted for the largest share of the wound care market, by product segment, in 2022. The wound care market is categorized into...
PR Newswire
11/10/2023

Accord Healthcare launches Accord Animal Health

But with the cost-of-living biting pet owners, vets are being squeezed by increasing numbers of pet owners who can't afford their bills coupled with price increases from suppliers. Many vets now feel that there is a large gap between what they need from their suppliers to support them and what they actually receive2 . But with the cost-of-living biting pet owners, vets are being squeezed by increasing numbers of pet owners who can't afford their bills coupled with price increases from…
PR Newswire
11/10/2023

Reshaping Dermatitis Disease Market Scenario with DLI's Drug Insights, Clinical…

With growing disease burden, there is a crucial need for the development of effective dermatitis treatment solutions. Pharma companies and medical researchers are investing in R&D endeavours with an aim to get a thorough understanding about the traits of this ailment so that they can develop efficient dermatitis medications and therapies. With growing disease burden, there is a crucial need for the development of effective dermatitis treatment solutions. Pharma companies and medical…
PR Newswire
11/10/2023

Cancer Market : Epidemiology Study, Drug Insights, Regulatory Consulting and…

Various medical experts, biotech firms, and pharma companies are conducting extensive cancer research & development activities. Their sole aim is to develop effective cancer diagnostic and treatment therapeutics that can be a boon to the mankind. Many of them have procured Disease Landscape Insight's healthcare consulting services for additional assistance. Various medical experts, biotech firms, and pharma companies are conducting extensive cancer research & development activities...
PR Newswire
11/10/2023

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of…

Renovaro Press Release ) ( GEDiCube press release ). GEDiCube intends to rebrand as Renovaro.AI. Avram Miller's career includes significant roles in the technology and medical industries. He co-founded Intel Capital and served as Intel's Corporate Vice President of Business Development. Before his career in High-Tech, he had a 13-year career in medical science. Over the last ten years, he re-engaged his interest in utilizing technology in health care. He has been advising prominent...
Nasdaq GlobeNewswire
11/10/2023

Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for…

In the process of championing its potentially revolutionary Precision Promise study, PanCAN recently selected the leading drug candidate of Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) known as pelareorep for their pivotal Phase 3 trial. Signalling even more confidence in pelareorep's potential, PanCAN also followed up the selection by rewarding Oncolytics with its second annual PanCAN Therapeutic Accelerator Award, which comes with a US$5 million grant to further develop leading-edge…
PR Newswire
11/10/2023

MC2 Therapeutics Announces Positive Phase 2a Results of Novel HSP90 Inhibitor…

MC2-32 (RGRN-305) a first in class, oral therapy targeting multiple pathways involved in Hidradenitis Suppurativa (HS) achieves highly positive data in randomized, double-blinded, placebo-controlled trial in 15 patients: Primary endpoint, HiSCR50 was met at week 16 by 6 out of 10 patients in the MC2-32 group vs. 1 out 5 in the placebo groupHiSCR75 and HiSCR90 were met by 5 and 3 out of 10 patients in the MC2-32 group, respectively vs. 0 in the placebo groupGreater improvement in the...
Nasdaq GlobeNewswire
11/10/2023

Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek…

At IDWeek, Novavax will present data on key COVID-19 vaccine attributes that drive people's vaccine choices, and clinical data from two studies comparing its Omicron BA.1 and BA.5 variant vaccines to its prototype COVID-19 vaccine's ability to induce superior neutralizing antibody responses to BA.1 and BA.5 viruses in individuals previously vaccinated with mRNA vaccines. At IDWeek, Novavax will present data on key COVID-19 vaccine attributes that drive people's vaccine choices, and clinical...
PR Newswire
11/10/2023

Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for…

Late-breaking poster to be presented titled: “Treatment Of Six Non-Active Secondary Progressive MS With Nasal Anti-CD3 Monoclonal Antibody (Foralumab): Safety, Biomarker, And Disability Outcomes” NEW YORK, Oct.11, 2023(GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq:TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced a late breaking poster titled, “Treatment Of Six...
Nasdaq GlobeNewswire
11/10/2023

Role of DLI in Post-Traumatic Stress Disorder Management- Navigating through…

Mental health disorders have been ignored since time immemorial. The associated taboo and ignorance of the masses about the importance of mental well-being slowed the research activities on the same. But with time, people are understanding that their mental well being is as important as their physical well-being. This has pushed industry participants to conducted R&D activities to develop diagnostic and treatment solutions for disorders like PTSD and anxiety. Mental health disorders have…
PR Newswire
11/10/2023
Altri  Comunicati